Detalhe da pesquisa
1.
Overall survival from tebentafusp versus nivolumab plus ipilimumab in first-line metastatic uveal melanoma: a propensity score-weighted analysis.
Ann Oncol
; 35(3): 317-326, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38048850
2.
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib.
Ann Oncol
; 34(7): 615-625, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37105265
3.
Spinal tumours: recommendations of the Polish Society of Spine Surgery, the Polish Society of Oncology, the Polish Society of Neurosurgeons, the Polish Society of Oncologic Surgery, the Polish Society of Oncologic Radiotherapy, and the Polish Society of Orthopaedics and Traumatology.
Eur Spine J
; 32(4): 1300-1325, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854861
4.
The Extent of Task Specificity for Visual and Tactile Sequences in the Auditory Cortex of the Deaf and Hard of Hearing.
J Neurosci
; 41(47): 9720-9731, 2021 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34663627
5.
Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAFV600 mutation-positive melanoma.
Ann Oncol
; 33(5): 544-555, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35131452
6.
Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.
Ann Oncol
; 33(9): 968-980, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716907
7.
Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma - real world multicenter cohort study.
J Eur Acad Dermatol Venereol
; 36(8): 1219-1228, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35279879
8.
Cobimetinib plus atezolizumab in BRAFV600 wild-type melanoma: primary results from the randomized phase III IMspire170 study.
Ann Oncol
; 32(3): 384-394, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33309774
9.
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)â.
Ann Oncol
; 32(4): 533-541, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33482247
10.
Early discontinuation of PD-1 blockade upon achieving a complete or partial response in patients with advanced melanoma: the multicentre prospective Safe Stop trial.
BMC Cancer
; 21(1): 323, 2021 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33765967
11.
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries.
J Eur Acad Dermatol Venereol
; 35(5): 1119-1132, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326646
12.
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation-positive melanoma receiving adjuvant vemurafenib.
Ann Oncol
; 31(1): 153-159, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31912791
13.
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee.
Ann Oncol
; 31(11): 1449-1461, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32763452
14.
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee.
Ann Oncol
; 31(11): 1435-1448, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32763453
15.
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network.
Ann Oncol
; 31(11): 1506-1517, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32891793
16.
Development and validation of a nomogram to predict recurrence and melanoma-specific mortality in patients with negative sentinel lymph nodes.
Br J Surg
; 106(3): 217-225, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30307046
17.
Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 'CREATE'.
Ann Oncol
; 29(3): 758-765, 2018 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29216400
18.
A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors.
Ann Oncol
; 28(3): 541-546, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28426120
19.
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'.
Ann Oncol
; 28(12): 3000-3008, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28950372
20.
Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group.
Ann Oncol
; 28(6): 1230-1242, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28184416